Fawaz G Haj Selected Research

Non-Receptor Type 1 Protein Tyrosine Phosphatase

1/2020	Hepatic protein-tyrosine phosphatase 1B disruption and pharmacological inhibition attenuate ethanol-induced oxidative stress and ameliorate alcoholic liver disease in mice.
11/2017	Protein tyrosine phosphatase 1B deficiency in podocytes mitigates hyperglycemia-induced renal injury.
1/2016	(-)-Epicatechin improves insulin sensitivity in high fat diet-fed mice.
1/2016	Pancreatic Protein Tyrosine Phosphatase 1B Deficiency Exacerbates Acute Pancreatitis in Mice.
1/2015	Protein-tyrosine phosphatase 1B substrates and metabolic regulation.
8/2013	Regulation of the SNARE-interacting protein Munc18c tyrosine phosphorylation in adipocytes by protein-tyrosine phosphatase 1B.
6/2013	Protein tyrosine phosphatase 1B regulates pyruvate kinase M2 tyrosine phosphorylation.
11/2012	(-)-Epicatechin prevents TNFα-induced activation of signaling cascades involved in inflammation and insulin sensitivity in 3T3-L1 adipocytes.
6/2004	Transgenic overexpression of protein-tyrosine phosphatase 1B in muscle causes insulin resistance, but overexpression with leukocyte antigen-related phosphatase does not additively impair insulin action.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fawaz G Haj Research Topics

Disease

18	Insulin Resistance 01/2018 - 01/2004
12	Inflammation (Inflammations) 01/2021 - 08/2011
11	Obesity 01/2017 - 04/2005
9	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2005
5	Body Weight (Weight, Body) 01/2017 - 08/2011
4	Hyperglycemia 01/2021 - 08/2011
4	Pancreatitis 01/2016 - 01/2014
4	Glucose Intolerance 11/2015 - 06/2014
3	Neoplasms (Cancer) 01/2019 - 11/2012
3	Fibrosis (Cirrhosis) 11/2017 - 07/2015
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2014 - 05/2011
2	Necrosis 01/2018 - 11/2012
2	Proteinuria 01/2017 - 01/2017
2	Dyslipidemias (Dyslipidemia) 11/2015 - 04/2015
2	Fatty Liver 08/2015 - 07/2012
2	Pain (Aches) 07/2015 - 07/2012
2	Metabolic Diseases (Metabolic Disease) 01/2015 - 05/2013
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2015 - 08/2011
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2013 - 05/2011
1	Liver Diseases (Liver Disease) 01/2021
1	Alcoholic Liver Diseases (Alcoholic Liver Disease) 01/2020
1	Atherosclerosis 11/2019
1	Endotoxemia 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2017
1	Albuminuria 11/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Alveolar Bone Loss 01/2017
1	Infections 01/2017
1	Periodontitis 01/2017
1	Weight Gain 11/2015
1	Overweight 05/2013

Drug/Important Bio-Agent (IBA)

19	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2004
14	Insulin (Novolin)FDA Link 11/2017 - 01/2004
11	Epoxide HydrolasesIBA 01/2021 - 05/2011
9	Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA 01/2020 - 06/2004
6	Catechin (Z 7300)IBA 01/2018 - 11/2012
5	EnzymesIBA 07/2015 - 08/2011
4	Proteins (Proteins, Gene)FDA Link 05/2019 - 06/2013
4	Urea (Carbamide)FDA LinkGeneric 01/2017 - 08/2015
3	CytokinesIBA 11/2019 - 07/2014
3	Streptozocin (Streptozotocin)FDA Link 11/2017 - 07/2012
3	Fatty Acids (Saturated Fatty Acids)IBA 11/2017 - 07/2012
3	Bile Acids and Salts (Bile Acids)IBA 01/2017 - 08/2012
3	CeruletideIBA 01/2016 - 03/2014
3	Pharmaceutical PreparationsIBA 01/2015 - 06/2013
2	Ethanol (Ethyl Alcohol)IBA 01/2021 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 11/2019 - 12/2016
2	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2018 - 07/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2017 - 08/2012
2	NitrogenIBA 01/2017 - 01/2017
2	Protein Tyrosine PhosphatasesIBA 01/2017 - 01/2005
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2017 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2016 - 04/2015
2	flavan-3-olIBA 12/2016 - 01/2016
2	ChemokinesIBA 12/2016 - 07/2014
2	Arginine (L-Arginine)FDA Link 01/2016 - 08/2015
2	Amino Acids FDA Link 08/2015 - 06/2013
2	Phosphotransferases (Kinase)IBA 08/2015 - 04/2015
2	FructoseIBA 04/2015 - 07/2014
2	AdiponectinIBA 04/2015 - 08/2012
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2015 - 11/2012
2	Non-Receptor Type 2 Protein Tyrosine PhosphataseIBA 01/2015 - 03/2014
2	PalmitatesIBA 05/2013 - 03/2011
2	Triglycerides (Triacylglycerol)IBA 01/2013 - 08/2011
2	LipidsIBA 08/2012 - 07/2012
2	LeptinIBA 08/2011 - 04/2005
1	AcidsIBA 01/2021
1	X-Box Binding Protein 1IBA 11/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	EndotoxinsIBA 01/2018
1	acetovanillone (apocynin)IBA 01/2018
1	Leptin ReceptorsIBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	shikoninIBA 11/2015
1	Protein Kinases (Protein Kinase)IBA 08/2015
1	Oxidoreductases (Dehydrogenase)IBA 08/2015
1	NADP (NADPH)IBA 08/2015
1	High Fructose Corn SyrupIBA 08/2015
1	setanaxibIBA 08/2015
1	Double-Stranded RNA (RNA, Double Stranded)IBA 08/2015
1	Choline (Choline Chloride)IBA 08/2015
1	Benzoic Acid (Potassium Benzoate)FDA Link 07/2015
1	4- (4- (3- (4- trifluoromethoxy- phenyl)ureido)cyclohexyloxy)benzoic acidIBA 07/2015
1	Epoxy Compounds (Epoxides)IBA 07/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 07/2015
1	MitogensIBA 04/2015
1	QuercetinIBA 04/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 06/2014
1	Sucrose (Saccharose)IBA 06/2014
1	Cyclooxygenase InhibitorsIBA 06/2014
1	alogliptinIBA 04/2014
1	Pioglitazone (Actos)FDA Link 04/2014
1	Messenger RNA (mRNA)IBA 06/2013
1	Branched-Chain Amino AcidsIBA 06/2013
1	Lipoproteins (Lipoprotein)IBA 01/2013
1	ResistinIBA 11/2012
1	Mitogen-Activated Protein KinasesIBA 11/2012
1	Interleukin-6 (Interleukin 6)IBA 11/2012

Therapy/Procedure

2	Therapeutics 01/2021 - 07/2012
2	Gastrectomy 01/2017 - 08/2012